Form 4: Parker-Hannifin VP & Controller Awarded SARs

Sentiment:

Executive Equity Grant


Angela R. Ives, VP & Controller of Parker-Hannifin Corp, was granted 1,394 Stock Appreciation Rights with a strike price of $742.97, vesting over three years.

Summary

  • Angela R. Ives, VP & Controller of Parker-Hannifin Corp (PH), was granted 1,394 Stock Appreciation Rights (SARs) on August 20, 2025.
  • The SARs have an exercise price of $742.97 per share.
  • The award vests in three equal annual installments, commencing on August 20, 2026.
  • The expiration date for these SARs is August 19, 2035.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned acquisition.

Sentiment

Score: 7

Explanation: The grant of equity-based compensation to a key executive is generally a positive signal, aligning management's interests with shareholders and incentivizing long-term performance. It reflects standard corporate governance practices.

Positives

  • The grant of Stock Appreciation Rights aligns management incentives with shareholder value creation, as SARs gain value only if the stock price increases above the exercise price.
  • The vesting schedule over three years encourages long-term commitment and performance from the VP & Controller.

Negatives

  • No direct negatives identified from the grant of SARs, as it is a standard form of executive compensation.

Future Outlook

The vesting schedule for the Stock Appreciation Rights indicates a future commitment to the company's performance over the next three years, with the first installment vesting on August 20, 2026, and the full award expiring on August 19, 2035.

Industry Context

The grant of Stock Appreciation Rights is a common executive compensation practice in the industrial manufacturing sector, aligning executive incentives with long-term shareholder value creation. Parker-Hannifin, a diversified manufacturer of motion and control technologies, utilizes such equity awards to retain key talent and motivate performance in a competitive industry landscape.

Comparison to Industry Standards

  • The use of Stock Appreciation Rights (SARs) as a form of long-term incentive compensation is standard practice among large industrial companies, similar to peers like Honeywell (HON), Eaton (ETN), and Rockwell Automation (ROK).
  • The vesting schedule over three years is typical for such awards, promoting executive retention and sustained performance, comparable to equity grants observed at companies like Emerson Electric (EMR) or Illinois Tool Works (ITW).
  • The exercise price being set at the market price on the grant date is also a standard feature of SARs, ensuring that executives benefit only from future stock price appreciation.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive CompensationGrant of 1,394 Stock Appreciation Rights to the VP & Controller, Angela R. Ives, under a Rule 10b5-1(c) plan.08/20/2025Aligns executive incentives with long-term shareholder value creation and promotes retention of key management personnel.

Stakeholder Impact

  • Shareholders: Potentially positive, as executive incentives are aligned with stock price appreciation, encouraging management to drive long-term value.
  • Employees: No direct impact on general employees, but it signals the company's approach to executive retention and performance incentives.

Next Steps

  • The SARs will vest in three equal annual installments starting August 20, 2026.
  • The reporting person will hold these SARs until their expiration on August 19, 2035, or until exercised.

Key Dates

DateDescription
08/20/2025Date of earliest transaction (grant of SARs).
08/22/2025Date of filing signature.
08/20/2026Date when the first of three equal annual installments of SARs begins to vest.
08/19/2035Expiration date of the Stock Appreciation Rights.

Recommendation

hold

This Form 4 filing reports a routine grant of Stock Appreciation Rights to a key executive, which is a standard component of executive compensation. While it aligns management incentives with shareholder interests, it does not present new information that would fundamentally alter the investment thesis for Parker-Hannifin, warranting a 'hold' recommendation based solely on this filing.

Keywords

Parker-Hannifin, PH, Stock Appreciation Rights, SARs, Executive Compensation, Form 4, Insider Transaction, Angela R. Ives, VP & Controller, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.